These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 15520478)

  • 1. Genomics of Mycobacterium tuberculosis: old threats & new trends.
    Ahmed N; Hasnain SE
    Indian J Med Res; 2004 Oct; 120(4):207-12. PubMed ID: 15520478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug-resistant tuberculosis in human immunodeficiency virus infected persons in Italy. The Italian Drug-Resistant Tuberculosis Study Group.
    Angarano G; Carbonara S; Costa D; Gori A
    Int J Tuberc Lung Dis; 1998 Apr; 2(4):303-11. PubMed ID: 9559401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extensively drug-resistant tuberculosis: new strains, new challenges.
    Banerjee R; Schecter GF; Flood J; Porco TC
    Expert Rev Anti Infect Ther; 2008 Oct; 6(5):713-24. PubMed ID: 18847407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug-resistant tuberculosis in the European Union: opportunities and challenges for control.
    Fears R; Kaufmann S; Ter Meulen V; Zumla A;
    Tuberculosis (Edinb); 2010 May; 90(3):182-7. PubMed ID: 20382566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An outbreak of multidrug-resistant tuberculosis involving HIV-infected patients of two hospitals in Milan, Italy. Italian Multidrug-Resistant Tuberculosis Outbreak Study Group.
    Moro ML; Gori A; Errante I; Infuso A; Franzetti F; Sodano L; Iemoli E
    AIDS; 1998 Jun; 12(9):1095-102. PubMed ID: 9662207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation and control of a large outbreak of multi-drug resistant tuberculosis at a central Lisbon hospital.
    Hannan MM; Peres H; Maltez F; Hayward AC; Machado J; Morgado A; Proenca R; Nelson MR; Bico J; Young DB; Gazzard BS
    J Hosp Infect; 2001 Feb; 47(2):91-7. PubMed ID: 11170771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ancestral Mycobacterium tuberculosis genotypes in India: implications for TB control programmes.
    Ahmed N; Ehtesham NZ; Hasnain SE
    Infect Genet Evol; 2009 Jan; 9(1):142-6. PubMed ID: 18992848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Multidrug-resistant tuberculosis. 5. Human immunodeficiency virus infection and multidrug-resistant tuberculosis].
    Fujita A
    Kekkaku; 1998 Nov; 73(11):679-85. PubMed ID: 9866931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors and outcome of human immunodeficiency virus-infected patients with sporadic multidrug-resistant tuberculosis in New York City.
    Mannheimer SB; Sepkowitz KA; Stoeckle M; Friedman CR; Hafner A; Riley LW
    Int J Tuberc Lung Dis; 1997 Aug; 1(4):319-25. PubMed ID: 9432387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Tuberculosis in Europe and Poland--new molecular families and new resistance patterns].
    Augustynowicz-Kopeć E; Zwolska Z
    Przegl Epidemiol; 2008; 62(1):113-21. PubMed ID: 18536233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of acquired MDR-TB and HIV co-infection.
    Deivanayagam CN; Rajasekaran S; Venkatesan R; Mahilmaran A; Ahmed PR; Annadurai S; Kumar S; Chandrasekar C; Ravichandran N; Pencillaiah R
    Indian J Chest Dis Allied Sci; 2002; 44(4):237-42. PubMed ID: 12437236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multidrug-resistant and extensively drug-resistant tuberculosis: implications for the HIV epidemic and antiretroviral therapy rollout in South Africa.
    Andrews JR; Shah NS; Gandhi N; Moll T; Friedland G;
    J Infect Dis; 2007 Dec; 196 Suppl 3():S482-90. PubMed ID: 18181698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spread of extensively drug-resistant tuberculosis.
    Samper S; Martín C
    Emerg Infect Dis; 2007 Apr; 13(4):647-8. PubMed ID: 17561563
    [No Abstract]   [Full Text] [Related]  

  • 15. The theoretical influence of immunity between strain groups on the progression of drug-resistant tuberculosis epidemics.
    Basu S; Orenstein E; Galvani AP
    J Infect Dis; 2008 Nov; 198(10):1502-13. PubMed ID: 18816192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Future prospects of molecular epidemiology in tuberculosis].
    Matsumoto T; Iwamoto T
    Kekkaku; 2009 Dec; 84(12):783-4. PubMed ID: 20077862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of outbreak- and nonoutbreak-related multidrug-resistant tuberculosis among human immunodeficiency virus-infected patients in a South African hospital.
    Sacks LV; Pendle S; Orlovic D; Blumberg L; Constantinou C
    Clin Infect Dis; 1999 Jul; 29(1):96-101. PubMed ID: 10433570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resurgence of tuberculosis: the perspective a dozen years later.
    Kamholz SL
    J Assoc Acad Minor Phys; 1996; 7(3):83-6. PubMed ID: 8803420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Tuberculosis and the HIV pandemic. Risk of nosocomial tuberculosis infection].
    Pedersen C; Kolmos HJ; Nielsen JO
    Ugeskr Laeger; 1997 Feb; 159(9):1233-8. PubMed ID: 9072866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human immunodeficiency virus-related tuberculosis and primary drug resistance in Bangkok, Thailand.
    Punnotok J; Shaffer N; Naiwatanakul T; Pumprueg U; Subhannachart P; Ittiravivongs A; Chuchotthaworn C; Ponglertnapagorn P; Chantharojwong N; Young NL; Limpakarnjanarat K; Mastro TD
    Int J Tuberc Lung Dis; 2000 Jun; 4(6):537-43. PubMed ID: 10864184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.